Format

Send to

Choose Destination
Handb Clin Neurol. 2014;120:773-85. doi: 10.1016/B978-0-7020-4087-0.00051-6.

Diabetic neuropathy.

Author information

1
Division of Endocrinology and Metabolism, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA. Electronic address: gcharno@lumc.edu.
2
Division of Endocrinology and Metabolism, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.

Abstract

Neuropathies related to diabetes mellitus can affect 60-70% of patients with diabetes. These can include peripheral polyneuropathies, mononeuropathies, and autonomic neuropathies. Control of glucose, lipids, and hypertension and cessation of smoking can limit onset and progression of these neuropathies. Besides control of the above listed risk factors, we do not have effective medications to treat the pathophysiologic mechanisms of diabetic neuropathies. Treatment is limited to ameliorating pain and correcting the end organ consequences of the neuropathic processes.

KEYWORDS:

Peripheral neuropathy; autonomic neuropathy; diabetic complications; mononeuropathy; polyneuropathy

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center